2023
DOI: 10.1016/j.ijbiomac.2023.125529
|View full text |Cite|
|
Sign up to set email alerts
|

RETRACTED: Physicochemical characterization, in vitro and in vivo evaluation of chitosan/carrageenan encumbered with Imatinib mesylate-polysarcosine nanoparticles for sustained drug release and enhanced colorectal cancer targeted therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(4 citation statements)
references
References 54 publications
0
4
0
Order By: Relevance
“…A recent study by Bhattacharya et al [ 89 ] focused on developing chitosan–carrageenan nanoparticles for the delivery of imatinib mesylate-poly sarcosine. Based on the experimental results, the authors concluded that these polysaccharide-based nanosystems are promising for the treatment of colon cancer, having great potential in actively targeting and reducing the dose-dependent toxicity of the carried drug.…”
Section: Drug Delivery Systems Based On Chitosan/cyclodextrins For Th...mentioning
confidence: 99%
See 1 more Smart Citation
“…A recent study by Bhattacharya et al [ 89 ] focused on developing chitosan–carrageenan nanoparticles for the delivery of imatinib mesylate-poly sarcosine. Based on the experimental results, the authors concluded that these polysaccharide-based nanosystems are promising for the treatment of colon cancer, having great potential in actively targeting and reducing the dose-dependent toxicity of the carried drug.…”
Section: Drug Delivery Systems Based On Chitosan/cyclodextrins For Th...mentioning
confidence: 99%
“…The opposite situation was observed for chitosan-based vehicles employed in colorectal cancer treatment, as the mucoadhesion and pH-sensitivity of this material attracted more interest towards developing orally administered chemotherapeutics [ 83 , 85 , 86 , 90 , 92 ]. On the other hand, creating chitosan-based delivery vehicles for intravenous administration imposed different targeting strategies, such as the use of folic acid to ensure selectivity towards cells with overexpressed folate receptors [ 82 ], loading with an imatinib mesylate drug that acts as a tyrosine kinase inhibitor, with specific targets of BCR-ABL and c-KIT kinases [ 89 ], and creating composites with magnetic nanoparticles to be guided under the application of an external magnetic field [ 93 , 94 ]. Regarding gastric cancer, only one of the proposed formulations was designed for oral administration considering the mucoadhesion of chitosan [ 120 ], whereas other carriers were developed to be injected intravenously (with targeting based on chitosan’s intrinsic properties [ 117 , 123 ] and the addition of GX1 as a targeting ligand [ 122 ]), intraperitoneally [ 119 ], and subcutaneously [ 121 ].…”
Section: Drug Delivery Systems Based On Chitosan/cyclodextrins For Th...mentioning
confidence: 99%
“…The traditional methods of rehabilitation have been mainly manual therapy and walking aids. However, in practice this may not always lead to the best outcomes [1]- [4]. Additionally, it's often difficult and time-consuming.…”
Section: Introductionmentioning
confidence: 99%
“…Occupational therapy goes a step further and is more involved in everyday activities and exercises. Constraint-induced movement therapy is a procedure where one of the arms is restrained to make sure the other one is used instead of the unaffected arm [4]- [6]. It is designed to help potentially recover lost functions in a more direct way.…”
Section: Introductionmentioning
confidence: 99%